An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Compounded peptides are being promoted and sold by wellness companies without adequate clinical evidence supporting their safety or efficacy. This presents an alarming safety concern, which ECRI and ISMP warned patients, BPC 157: Miracle Healing Peptide or Hidden Danger? What Are Injectable Peptides? Here's Why Doctors Are Worried About the Latest TikTok Wellness Fad. WSJ